| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |